These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3296725)

  • 21. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
    Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicology of indecainide hydrochloride in mice, rats, and dogs.
    Sandusky GE; Meyers DB
    Fundam Appl Toxicol; 1985 Feb; 5(1):175-81. PubMed ID: 3921422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerance of Ethmozine (moricizine HCl) in placebo-controlled trials.
    Morganroth J; Pratt CM; Kennedy HL; Singh SN; Platt ML; Baker BJ; Mason DT
    Am J Cardiol; 1987 Oct; 60(11):48F-51F. PubMed ID: 3310585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicology of indecainide hydrochloride after intravenous administration to rats and dogs.
    Sandusky GE; Meyers DB
    Toxicol Lett; 1985 Aug; 26(2-3):107-10. PubMed ID: 4035704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of proarrhythmic effects from quinidine in the outpatient treatment of benign or potentially lethal ventricular arrhythmias.
    Morganroth J; Horowitz LN
    Am J Cardiol; 1985 Oct; 56(10):585-7. PubMed ID: 3901720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lorcainide for high-frequency ventricular arrhythmia: preliminary results of a short-term double-blind and placebo-controlled crossover study and long-term follow-up.
    Singh SN; DiBianco R; Kostroff LI; Fletcher RD; Cockrell JL
    Am J Cardiol; 1984 Aug; 54(4):22B-28B. PubMed ID: 6380261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents.
    Kehoe RF; MacNeil DJ; Zheutlin TA; Ezri MD; Nazari J; Spangenberg RB; Dunnington C; Lueken M
    Am J Cardiol; 1993 Aug; 72(4):56A-66A. PubMed ID: 8346728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-related antiarrhythmic effects of nicainoprol in patients with chronic ventricular arrhythmias--a double-blind, placebo-controlled, cross-over multicentre trial. Nicainoprol Study Group.
    Schneider W; Reifart N; Blaeser A; Ostrowski J; Kaltenbach M; Kober G
    Eur Heart J; 1991 Aug; 12(8):900-8. PubMed ID: 1915428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation and treatment of ventricular arrhythmias: an update.
    McCollam PL; Parker RB
    Clin Pharm; 1991 Mar; 10(3):195-205. PubMed ID: 2040126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term efficacy of oral encainide in frequent and repetitive ventricular arrhythmias.
    Bongiorni MG; Levorato D; Arlotta C; Paperini L; Contini C
    Eur Heart J; 1988 Jul; 9(7):765-76. PubMed ID: 3139413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of flecainide in patients with stable ventricular ectopic beats. Multicenter trial of the Italian Study Group on the Electrophysiology of Arrhythmias.
    G Ital Cardiol; 1989 Apr; 19(4):360-70. PubMed ID: 2502464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recainam, a potent new antiarrhythmic agent: effects on complex ventricular arrhythmias.
    Anastasiou-Nana MI; Anderson JL; Hampton EM; Nanas JN; Heath BM
    J Am Coll Cardiol; 1986 Aug; 8(2):427-35. PubMed ID: 3734265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term continuous electrocardiographic recordings and electrophysiologic testing to select patients with ventricular arrhythmias for drug trials and to determine antiarrhythmic drug efficacy.
    Bigger JT
    Am J Cardiol; 1986 Aug; 58(5):58C-65C. PubMed ID: 3529907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics.
    Roden DM; Reele SB; Higgins SB; Mayol RF; Gammans RE; Oates JA; Woosley RL
    N Engl J Med; 1980 Apr; 302(16):877-82. PubMed ID: 6767186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of efficacy during long-term cifenline therapy: development of antiarrhythmic resistance?
    Mohiuddin SM; Hee TT; Hunter CB; Hilleman DE; Sketch MH
    Ann Pharmacother; 1993 May; 27(5):550-4. PubMed ID: 8347900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous and oral lorcainide: assessment of central nervous system toxicity and antiarrhythmic efficacy.
    Vlay SC; Mallis GI
    Am Heart J; 1986 Mar; 111(3):452-5. PubMed ID: 3953352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral antiarrhythmic agents for ventricular arrhythmias.
    Meissner MD; Nestico PF; Morganroth J
    Clin Ther; 1986; 8(6):595-604. PubMed ID: 3539346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of Holter electrocardiogram in the evaluation of anti-arrhythmia therapy].
    Meoli P; Sanna G
    G Ital Cardiol; 1987 Dec; 17(12):1114-20. PubMed ID: 3332646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
    Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP
    Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of Holter's dynamic ECG a as predictor of the effectiveness of anti-arrhythmia therapy].
    Sanna GP
    G Ital Cardiol; 1986 Aug; 16(8):663-6. PubMed ID: 3792732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.